Interstitial Lung Disease Program

U.S. News & World Report Best National Pulmonology Hospitals

Interstitial Lung Disease (ILD) is composed of a diverse group of conditions with shared clinical, radiographic and pathologic features. Common ILDs include idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP) and connective tissue disease-associated ILD (CTD-ILD), due to rheumatoid arthritis, systemic sclerosis, Sjogren's syndrome, polymyositis, dermatomyositis, lupus, or mixed connective tissue disease. The treatment of ILD generally targets the immune system or fibrotic pathways. An accurate ILD diagnosis is critical, as therapies targeting the immune system have been shown to harm individuals with IPF, while therapies targeting fibrotic pathways are of unclear benefit in those with HP and CTD-ILD.

The UC Davis ILD Program specializes in the diagnostic evaluation and treatment of patients with ILD. Our team is dedicated to providing state-of-the-art care to patients and their families.  Our multi-disciplinary team includes pulmonologists, rheumatologists, radiologists and pathologists with extensive ILD experience. This team meets regularly for multi-disciplinary discussion of patients seen in our clinic to establish an accurate diagnosis and initiate appropriate therapy. We also engage in cutting edge research, provide access to numerous clinical trials and maintain active collaborations with ILD centers around the country.

Clinical Information

The Interstitial Lung Disease Clinic is located at UC Davis Medical Group, 2825 J Street, Suite 400 in Sacramento, Calif. 95817. Our clinic is located at the corner of 28th and J Streets. We have a comfortable reception area, and plenty of examination and teaching rooms. The phone number for the ILD office is 916-734-5360 and fax 916-734-5582. For questions regarding the ILD clinical program, please email or call Timothy Kern ( at 916-734-5360.

Research Information

We conduct basic, clinical and translational ILD research at UC Davis. We maintain a large clinical registry along with biorepository where we store blood and lung samples for basic and translational research. We also take part in several ILD clinical trials for patients interested in enrolling. For questions regarding the UC Davis ILD registry and biorepository, along with currently enrolling clinical trials, please email or call Elena Foster ( or Maya Juarez ( at 916-734-3650.

Central Valley Pulmonary Fibrosis Support Group

For questions regarding the patient support group, please contact Maya Juarez or Elena Foster,

Meet the Team

Justin Oldham, M.D., M.S.

Richart Harper, M.D.

Timothy Kern, RN-BC, BSN
ILD Nurse Coordinator

Elena Foster, M.S.
Research Coordinator

Brian Morrissey, M.D.
Associate Director

William Stoll, RRT
ILD Respiratory Therapist

Michael Kadoch, MD.
Chief Cardiothoracic Radiologist

Maya Juarez, M.S.
Research Coordinator

March 2019 Interstitial Lung Disease Seminar

Pulmonary Fibrosis: The Journey from Diagnosis to Treatment - An All-Day Seminar for Patients, Caregivers, and Families 

The University of California at San Francisco (UCSF), University of California at Davis (UCD) and Stanford University have collaborated every other year since 2009 to provide a multi-disciplinary seminar for patients, family members, and caregivers. In March 2019, Stanford University hosted the event with over 200 participants who heard from experts on topics related to the ‘journey’ from receiving a diagnosis of ILD through all potential treatment options. Multiple exhibitors had information and personnel available to interact with patients, families and caregivers to provide them information on local and online patient support groups, palliative care and hospice services, choices of oxygen equipment, caregiver support, clinical research trials, and local pulmonary rehabilitation programs.

Lecture slides are available at the following links

Overview of Interstitial Lung Disease: ILD 101The Multidisciplinary Approach-Case #1;  Non-Pharmacologic Management: Palliative Care, Oxygen, Pulmonary Rehabilitation and Support GroupsThe Multidisciplinary Approach-Case #2Lung Transplant EvaluationLung Transplant Surgery and Recovery;  and Prospects for Stem Cell-Based Therapies.